Search For "serum"
CII to work with Serum Institute to expand vaccination across small towns,
Updated : 4 years, 7 months ago IST
New Delhi [India], July 30 (ANI): The Confederation of Indian Industry (CII) has entered into an agreement with the Serum Institute of India (SII) to accelerate COVID-19 vaccination in partnership with industry, including healthcare providers.
Read More
France includes Covishield in list of approved vaccines for travel to coun
Updated : 4 years, 7 months ago IST
Paris [France), July 19 (ANI): France on Monday included Covishield produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University in the list of approved vaccines for travel to the country.
Read More
Good news for travellers that Covishield recognised by 16 European nations
Updated : 4 years, 8 months ago IST
New Delhi [India], July 17 (ANI): Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Saturday said that it was good news for international travellers that Covishield, the Indian version of the Oxford-Astrazeneca vaccine was now recognised and accepted by 16 E
Read More
No application received for EU authorisation of Covishield, says European
Updated : 4 years, 8 months ago IST
New Delhi [India], July 16 (ANI): The European Medicines Agency (EMA) said it has not received any application from the COVID-19 vaccine Covishield maker Serum Institute of India (SII) for authorisation.
Read More
RDIF, SII to start production of Sputnik V COVID-19 vaccine in India from
Updated : 4 years, 8 months ago IST
New Delhi [India], July 13 (ANI): The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and Serum Institute of India (SII), announced cooperation to produce in India the Russian Sputnik vaccine against coronavirus.
Read More
Sputnik V to be produced at SII from September: RDIF
Updated : 4 years, 8 months ago IST
Moscow [Russia], July 13 (ANI): The first batch of Sputnik vaccine is expected to be produced at Serum Institute of India (SII)'s facilities in September, said Russian Direct Investment Fund (RDIF), the country's sovereign wealth fund on Tuesday.
Read More
15 EU countries recognise Covishield vaccine, says WHO Chief Scientist
Updated : 4 years, 8 months ago IST
Geneva [Switzerland], July 10 (ANI): World Health Organisation (WHO) chief scientist Soumya Swaminathan on Friday said 15 countries in the European Union (EU) now recognise Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University
Read More
Belgium recognises Indian-made Covishield vaccine
Updated : 4 years, 8 months ago IST
New Delhi [India], July 9 (ANI): Belgium has recognised the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University, said the Embassy of Belgium in India on Friday.
Read More
Union Minister Mansukh Mandaviya visits SII vaccine plant in Pune
Updated : 4 years, 8 months ago IST
Pune (Maharashtra) [India], July 2 (ANI): Union Minister Mansukh Mandaviya on Friday visited a vaccine manufacturing plant of the Serum Institute of India in Pune to review the production of vaccines.
Read More
Netherlands becomes latest EU country to approve Covishield vaccine
Updated : 4 years, 8 months ago IST
Amsterdam [Netherlands], July 2 (ANI): The Netherlands became the latest European Union (EU) country to approve the Serum Institute of India (SII)-manufactured Covishield vaccine for travellers, days after India pushed for the approval of its COVID-19 vaccines in Europe.
Read More
Switzerland, Iceland, 7 EU nations okay SII's Covishield vaccine, day afte
Updated : 4 years, 8 months ago IST
Zurich [Switzerland], July 1 (ANI): A day after external affairs minister S Jaishankar said he has taken up with European Union to accept COVID-19 vaccines, such as Covishield and Covaxin, for Indian nationals travelling to Europe, Switzerland, Iceland and seven European Union countries on T
Read More
'Submit results on Covavax adult trials first': Govt panel to SII on Covid
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sources on
Read More